Our Research Publications
Updated August 2024
Pagination
- Previous page
- Page 24
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Lazarus A | 2018 | Blood.ca website | View ResearchUnit: How does anti-D prevent hemolytic disease of the fetus and newborn? Lessons from a mouse model | Other | Other |
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A | 2018 | J Thromb Haemost | View Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Health care providers | Basic research |
Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Warkentin TE | 2018 | J Thromb Haemost | View Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Health care providers | Benchmarking and standard setting |
Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Ning S, Heddle NM, Acker JP | 2018 | Transfus Med Rev | View Exploring donor and product factors and their impact on red cell post-transfusion outcomes | Health care providers | Clinical research |
Modeling the optimal ethnic composition of an adult stem cell registry | Blake JT, McTaggart K, Killeen D | 2018 | Eur J Oper Res | View Modeling the optimal ethnic composition of an adult stem cell registry | Blood operators | New or improved product or process |
Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Branch D | 2018 | Blood.ca website | View Concentré de recherche: Rôle du groupe sanguin dans le déclenchement d'une hémolyse après l'administration d'immunoglobulines | Researchers | Basic research |
Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Devine DV | 2018 | JAMA Oncol | View Pathogen inactivation strategies to improve blood safety: Let's not throw pathogen-reduced platelets out with their bath water | Researchers | New or improved product or process |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Plasma components | Health care providers | Benchmarking and standard setting |
Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | MacIsaac J, Siddiqui R, Jamula E, Li N, Baker S, Webert KE, Evanovitch D, Heddle NM, Arnold DM | 2018 | Transfusion | View Systematic review of rituximab for autoimmune diseases: a potential alternative to intravenous immune globulin | Researchers | Clinical research |
Therapeutic Apheresis | Pavenski K | 2018 | Clinical Guide to Transfusion | View Therapeutic Apheresis | Health care providers | Benchmarking and standard setting |
Blood bag spiking procedure | Shimla S, Jenkins C, McTaggart K | 2018 | Blood.ca website | View Blood bag spiking procedure | Other | Other |
GPIb? is required for platelet-mediated hepatic thrombopoietin generation | Xu M, Li J, Neves MAD, Zhu G, Carrim N, Yu R, Gupta S, Marshall J, Rotstein O, Peng J, Hou M, Kunishima S, Ware J, Branch DR, Lazarus A, Ruggeri ZM, Freedman J, Ni H | 2018 | Blood | View GPIb? is required for platelet-mediated hepatic thrombopoietin generation | Researchers | Basic research |
Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Greco-Stewart V, Kiernan J, Killeen D, Haun S, Mercer D, Young K, Liwski RS, Allan DS | 2018 | Transfusion | View Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection | Health care providers | Clinical research |
Immune Globulin Products | Harding R, Lazarus A | 2018 | Clinical Guide to Transfusion | View Immune Globulin Products | Health care providers | Other |
Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Khadadah F, Callum J, Shelton D, Lin Y | 2018 | Transfusion | View Improving quality of care for patients with iron deficiency anemia presenting to the emergency department | Health care providers | Clinical research |
Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia | Nazy I, Clare R, Staibano P, Warkentin TE, Larché M, Moore JC, Smith JW, Whitlock RP, Kelton JG, Arnold DM | 2018 | J Thromb Haemost | View Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia | Researchers | Clinical research |
Modulating Intracellular Ice Growth with Cell-Permeating Small-Molecule Ice Recrystallization Inhibitors | Poisson JS, Acker JP, Briard JG, Meyer JE, Ben RN | 2018 | Langmuir | View Modulating Intracellular Ice Growth with Cell-Permeating Small-Molecule Ice Recrystallization Inhibitors | Researchers | Basic research |
The Monocyte Monolayer Assay: Past, Present and Future | Tong TN, Cen S, Branch DR | 2018 | Transfus Med Rev | View The Monocyte Monolayer Assay: Past, Present and Future | Researchers | Basic research |
Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against Staphylococcus aureus biofilms | Kumaran D, Taha M, Yi Q, Ramirez-Arcos S, Diallo JS, Carli A, Abdelbary H | 2018 | Front Microbiol | View Does treatment order matter? Investigating the ability of bacteriophage to augment antibiotic activity against Staphylococcus aureus biofilms | Researchers | Basic research |
rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kasermann F, Zuercher AW | 2018 | J Immunol | View rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs | Researchers | Basic research |
Hemolytic Disease of the Fetus and Newborn and Perinatal Immune Thrombocytopenia | Clarke G, Hannon J | 2018 | Clinical Guide to Transfusion | View Hemolytic Disease of the Fetus and Newborn and Perinatal Immune Thrombocytopenia | Health care providers | Other |
Concentré de recherche: Comment l'anti-D est-il capable d'empêcher la maladie hémolytique du foetus et du nouveau-né? Réponses à l'aide d'un modèle murin | Lazarus A | 2018 | Blood.ca website | View Concentré de recherche: Comment l'anti-D est-il capable d'empêcher la maladie hémolytique du foetus et du nouveau-né? Réponses à l'aide d'un modèle murin | Other | Other |
Natural, not immune; classical, not alternative | Warkentin TE | 2018 | Blood | View Natural, not immune; classical, not alternative | Researchers | Other |
Development of a proof of principle for universal neutralization of antibiotics in cord blood by-products used for sterility testing | Kou Y, Halpenny M, Elmoazzen H, Ramirez-Arcos S | 2018 | Transfusion | View Development of a proof of principle for universal neutralization of antibiotics in cord blood by-products used for sterility testing | Researchers | New or improved product or process |
Targeting transfusion-related acute lung injury: the journey from basic science to novel therapies | Semple JW, McVey MJ, Kim M, Rebetz J, Kuebler WM, Kapur R | 2018 | Crit Care Med | View Targeting transfusion-related acute lung injury: the journey from basic science to novel therapies | Researchers | Basic research |
Thromboelastometry reveals similar hemostatic properties of purified fibrinogen and a mixture of purified cryoprecipitate protein components | Qadri SM, Eltringham-Smith LJ, Bhakta V, Sheffield WP | 2018 | Clin Chem Lab Med | View Thromboelastometry reveals similar hemostatic properties of purified fibrinogen and a mixture of purified cryoprecipitate protein components | Researchers | Basic research |
Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale | Douketis JD SA, Anderson JM, Arnold DM, Bates SM, Blostein M, Carrier M, Caprini JA, Clark NP, Coppens M, Dentali F, Duncan J, Gross PL, Kassis J, Kowalski S, Lee AY, Gal GL, Templier GL, Li N, MacKay E, Shah V, Shivakumar S, Solymoss S, Spencer FA, Syed S, Tafur AJ, Vanassche T, Thiele T, Wu C, Yeo E, Schulman S. | 2018 | Thromb Haemost | View Erratum to: The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) Study for Patients on a Direct Oral Anticoagulant who Need an Elective Surgery or Procedure: Design and Rationale | Researchers | Clinical research |
Circulare d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleuccoyté (PD) | Jenkins C | 2018 | Blood.ca website | View Circulare d'information utilisation de composants sanguins humains: Culot globulaire partiellement déleuccoyté (PD) | Health care providers | Benchmarking and standard setting |
Prehospital fresh frozen plasma: Universal life saver or treatment in search of a target population? | Makris M, Iorio A | 2018 | Res Pract Thromb Haemost | View Prehospital fresh frozen plasma: Universal life saver or treatment in search of a target population? | Health care providers | Clinical research |
Quality of evidence-based guidelines for transfusion of red blood cells and plasma: A systematic review | Pavenski K, Stanworth S, Fung M, Wood EM, Pink J, Murphy MF, Hume H, Nahirniak S, Webert KE, Tanael S, Landry D, Shehata N | 2018 | Transfus Med Rev | View Quality of evidence-based guidelines for transfusion of red blood cells and plasma: A systematic review | Researchers | Clinical research |
Perforation des sacs de composants sanguins | Shimla S, Jenkins C, McTaggart K | 2018 | Blood.ca website | View Perforation des sacs de composants sanguins | Other | Other |
Apolipoprotein A-IV binds alpha II beta 3 integrin and inhibits thrombosis | Xu XR, Wang Y, Adili R, Ju L, Spring CM, Jin JW, Yang H, Neves MAD, Chen P, Yang Y, Lei X, Chen Y, Gallant RC, Xu M, Zhang H, Song J, Ke P, Zhang D, Carrim N, Yu S-Y, Zhu G, She Y-M, Cyr T, Fu W, Liu G, Connelly PW, Rand ML, Adeli K, Freedman J, Lee JE, Tso P, Marchese P, Davidson WS, Jackson SP, Zhu C, Ruggeri ZM, Ni H | 2018 | Nat Commun | View Apolipoprotein A-IV binds alpha II beta 3 integrin and inhibits thrombosis | Researchers | Basic research |
Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration | Cloutier N, Allaeys I, Marcoux G, Machlus KR, Mailhot B, Zufferey A, Levesque T, Becker Y, Tessandier N, Melki I, Zhi H, Poirier G, Rondina MT, Italiano JE, Flamand L, McKenzie SE, Cote F, Nieswandt B, Khan WI, Flick MJ, Newman PJ, Lacroix S, Fortin PR, Boilard E | 2018 | PNAS | View Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration | Researchers | Basic research |
When can patients on direct anticoagulants have surgery? | de Wit K | 2018 | CanadiEM website | View When can patients on direct anticoagulants have surgery? | Health care providers | Other |
Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018 | Chambers C, Hickman R, Sabaiduc S, Chan T, Jassem A, Rose C, Krajden M, Skowronski DM, Petric M, De Serres G, Martineau C, Charest H, Winter A-L, Gubbay JB, Dickinson JA, Fonseca K, Drews SJ, Bastien N, Li Y | 2018 | Clin Infect Dis | View Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010–2011 to 2017–2018 | Researchers | Clinical research |
Les immunoglobulines | Harding RS, Lazarus A | 2018 | Guide de la pratique transfusionnelle | View Les immunoglobulines | Health care providers | Other |
Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Kim K, Tarr GAM, Chui L, Drews S, Pang X-L, Lee BE, Ali S, Nettel-Aguirre A, Vanderkooi OG, Berenger BM, Dickinson J, Tarr PI, MacDonald J, Freedman SB | 2018 | Clin Infect Dis | View Performance of Stool-testing Recommendations for Acute Gastroenteritis When Used to Identify Children With 9 Potential Bacterial Enteropathogens | Health care providers | Clinical research |
Severe autoimmune LMWH-induced thrombocytopenia presenting with aortic thromboses, adrenal hemorrhage and pulmonary embolism: response to high-dose intravenous immunoglobulin | Nero J, Araneta P, Warkentin T, Moodley O | 2018 | Can J Gen Intern Med | View Severe autoimmune LMWH-induced thrombocytopenia presenting with aortic thromboses, adrenal hemorrhage and pulmonary embolism: response to high-dose intravenous immunoglobulin | Health care providers | Clinical research |
Concentrés pour les troubles de l'hémostase et l'angioedéme héréditaire | Poon MC, Goodyear D, Rydz N, Lee A | 2018 | Guide de la pratique transfusionnelle | View Concentrés pour les troubles de l'hémostase et l'angioedéme héréditaire | Health care providers | Benchmarking and standard setting |
Using anti-Xa level for adjusting intravenous unfractionated heparin infusion in peripartum thromboembolic disease | Tse E, Khurana R, Clarke G, Sia W | 2018 | Obstet Med | View Using anti-Xa level for adjusting intravenous unfractionated heparin infusion in peripartum thromboembolic disease | Health care providers | New or improved product or process |
Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion | Sullivan HC, Arthur CM, Thompson L, Patel SR, Stowell SR, Hendrickson JE, Lazarus AH | 2018 | Transfusion | View Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma components | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Plasma components | Health care providers | Benchmarking and standard setting |
Closing in on DEHP-free red blood cell concentrate containers | Almizraq RJ, Acker J | 2018 | Transfusion | View Closing in on DEHP-free red blood cell concentrate containers | Researchers | New or improved product or process |
Albumine | Clarke G, Yan M | 2018 | Guide de la pratique transfusionnelle | View Albumine | Health care providers | Other |
Risk-based decision making in transfusion medicine | Leach Bennett J, Devine DV | 2018 | Vox Sang | View Risk-based decision making in transfusion medicine | Researchers | New or improved product or process |
Human T-cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada | O'Brien SF, Yi Q-L, Goldman M, Grégoire Y, Delage G | 2018 | Vox Sang | View Human T-cell lymphotropic virus: A simulation model to estimate residual risk with universal leucoreduction and testing strategies in Canada | Researchers | New or improved product or process |
Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review | Rash JA, Buckley N, Busse JW, Campbell TS, Corace K, Cooper L, Flusk D, Iorio A, Lavoie KL, Poulin PA, Skidmore B | 2018 | Systematic Reviews | View Healthcare provider knowledge, attitudes, beliefs, and practices surrounding the prescription of opioids for chronic non-cancer pain in North America: protocol for a mixed-method systematic review | Researchers | Clinical research |
An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study | Zeller MP, Barty R, Dunbar NM, Elahie A, Flanagan P, Garritsen H, Kutner JM, Pagano MB, Poglod R, Rogers TS, Staves J, van Wordragen-Vlaswinkel M, Zwaginga JJ, Murphy MF, Heddle NM, Yazer MH | 2018 | Transfusion | View An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study | Health care providers | Clinical research |
Mechanisms of action and immunomodulation by IVIg | Khan R, Lazarus A | 2018 | Antibody Therapy: Substitution - Immunomodulation - Monoclonal Immunotherapy | View Mechanisms of action and immunomodulation by IVIg | Health care providers | Other |
Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Jenkins C | 2018 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Plaquettes | Health care providers | Benchmarking and standard setting |